☰

Samuel T. Haile, Ph.D. - Publications

Affiliations: 
2013 Biological Sciences University of Maryland, Baltimore County, Baltimore, MD, United States 
Area:
Immunology, Microbiology Biology, Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Simonetta F, Lohmeyer JK, Hirai T, Maas-Bauer K, Alvarez M, Wenokur AS, Baker J, Aalipour A, Ji X, Haile ST, Mackall CL, Negrin R. Allogeneic CAR-invariant Natural Killer T Cells Exert Potent Antitumor Effects Through Host CD8 T Cell Cross-Priming. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34376537 DOI: 10.1158/1078-0432.CCR-21-1329  0.611
2020 Murty S, Haile ST, Beinat C, Aalipour A, Alam IS, Murty T, Shaffer TM, Patel CB, Graves EE, Mackall CL, Gambhir SS. Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model. Oncoimmunology. 9: 1757360. PMID 32923113 DOI: 10.1080/2162402X.2020.1757360  0.577
2019 Simonetta F, Hirai T, Lohmeyer JK, Maas-Bauer K, Alvarez M, Wenokur AS, Baker J, Aalipour A, Haile S, Mackall CL, Negrin RS. Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming Blood. 134: 867-867. DOI: 10.1016/J.Bbmt.2019.12.109  0.67
2018 Mount CW, Majzner RG, Sundaresh S, Arnold EP, Kadapakkam M, Haile S, Labanieh L, Hulleman E, Woo PJ, Rietberg SP, Vogel H, Monje M, Mackall CL. Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M diffuse midline gliomas. Nature Medicine. PMID 29662203 DOI: 10.1038/S41591-018-0006-X  0.534
2018 Martinez EM, Klebanoff SD, Secrest S, Romain G, Haile ST, Emtage PCR, Gilbert AE. High-Throughput Flow Cytometric Method for the Simultaneous Measurement of CAR-T Cell Characterization and Cytotoxicity against Solid Tumor Cell Lines. Slas Discovery : Advancing Life Sciences R & D. 2472555218768745. PMID 29634393 DOI: 10.1177/2472555218768745  0.52
2018 Mount CW, Majzner R, Sundaresh S, Arnold EP, Kadapakkam M, Haile S, Labanieh L, Woo P, Rietberg SP, Vogel H, Monje M, Mackall CL. Abstract 958: Anti-GD2 chimeric antigen receptor T cells as a potent immunotherapy regimen in xenograft models of histone 3 K27M mutant diffuse midline glioma Immunology. 78: 958-958. DOI: 10.1158/1538-7445.Am2018-958  0.586
2018 Mount C, Majzner R, Sundaresh S, Arnold E, Kadapakkam M, Haile S, Labanieh L, Woo P, Rietberg S, Vogel H, Monje M, Mackall C. DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA Neuro-Oncology. 20: i56-i56. DOI: 10.1093/Neuonc/Noy059.129  0.429
2016 Haile ST, Conner J, Mackall C. Abstract 2304: Attenuated oncolytic virus HSV1716 increasesin vivoexpansion of GD2- targeting CAR T cells in murine solid tumor models Cancer Research. 76: 2304-2304. DOI: 10.1158/1538-7445.Am2016-2304  0.652
2014 Ostrand-Rosenberg S, Horn LA, Haile ST. The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 193: 3835-41. PMID 25281753 DOI: 10.4049/Jimmunol.1401572  0.756
2014 Haile ST, Horn LA, Ostrand-Rosenberg S. A soluble form of CD80 enhances antitumor immunity by neutralizing programmed death ligand-1 and simultaneously providing costimulation. Cancer Immunology Research. 2: 610-5. PMID 24819296 DOI: 10.1158/2326-6066.Cir-13-0204  0.741
2013 Haile ST, Dalal SP, Clements V, Tamada K, Ostrand-Rosenberg S. Soluble CD80 restores T cell activation and overcomes tumor cell programmed death ligand 1-mediated immune suppression. Journal of Immunology (Baltimore, Md. : 1950). 191: 2829-36. PMID 23918985 DOI: 10.4049/Jimmunol.1202777  0.793
2013 Haile S, Dalal SP, Clements V, Tamada K, Ostrand-Rosenberg S. Abstract 462: Soluble CD80 restores T-cell activation and overcomes tumor cell programmed death ligand-1-mediated suppression. Cancer Research. 73: 462-462. DOI: 10.1158/1538-7445.Am2013-462  0.794
2013 Dalal SP, Haile S, Somasundaram P, Ostrand-Rosenberg S. Abstract 1264: Mutated CD80 may facilitate T-cell activation by inhibiting PDL1-PD1 suppression and by costimulating. Cancer Research. 73: 1264-1264. DOI: 10.1158/1538-7445.Am2013-1264  0.748
2012 Schuberth PC, Jakka G, Jensen SM, Wadle A, Gautschi F, Haley D, Haile S, Mischo A, Held G, Thiel M, Tinguely M, Bifulco CB, Fox BA, Renner C, Petrausch U. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma. Gene Therapy. 20: 386-95. PMID 22739387 DOI: 10.1038/gt.2012.48  0.424
2011 Haile ST, Bosch JJ, Agu NI, Zeender AM, Somasundaram P, Srivastava MK, Britting S, Wolf JB, Ksander BR, Ostrand-Rosenberg S. Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80. Journal of Immunology (Baltimore, Md. : 1950). 186: 6822-9. PMID 21555531 DOI: 10.4049/Jimmunol.1003682  0.716
2010 Haile ST, Bosch J, Agu N, Ostrand-Rosenberg S. Abstract 5309: Programmed Death Ligand-1 expression on the cell surface is regulated by Costimulatory Molecule CD80 expressed by cancer vaccines Cancer Research. 70: 5309-5309. DOI: 10.1158/1538-7445.Am10-5309  0.744
Show low-probability matches.